CClinicalTrials.gg
CompletedNCT05803837Updated Apr 7, 2023

Thoracotomy Effects on Pulmonary Function Test and Chest Expansion

An observational study in Adolescent Idiopathic Scoliosis, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-04-07.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The purpose of the present study was to investigate the effect that corrective surgery for scoliosis would have on pulmonary function as well as the circumference of the chest. As a result, the current investigation was carried out on thirty individuals who had idiopathic scoliosis and had been admitted to the hospital. Before the surgery, after it had been completed (on the fifth day), and again three months later, the pulmonary function was tested.

Read the detailed description

The purpose of this study was to see how corrective scoliosis surgery affected pulmonary function and chest circumference. As a result, the current investigation was carried out on 30 individuals brought to the hospital with idiopathic scoliosis. The pulmonary function was assessed before surgery, on the fifth day following surgery, and three months thereafter.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis

Browse trials for

Keywords

  • lung functions and thoracotomy
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 30 is below the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

thirty patients Participants have received a good explanation of the treatment and measurement device. aged between 12 and 18 years with AIS; the patients were admitted to hospital

Inclusion criteria

  • Adolescent idiopathic scoliosis

Exclusion criteria

Exclusion Criteria:

  • smoking.
  • Associated comorbidity that affects PFT.
  • Any contraindication interfering with performing spirometry.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Target follow-up
10 Days
Patient registry
Yes

Groups and cohorts

  • intervention group

    one group

06

What researchers measure

Primary outcomes

  1. chest expansion

    chest circumference meaurement

    Time frame: 10 months

  2. PFT

    PULMONARY FUNCTION TEST * Vital capacity (Liter). * Forced VITAL Capacity (Liter). * Maximal voluntary breathing (Liter).

    Time frame: 10 months for each parameter

Secondary outcomes

  1. cobb angle

    In terms of measuring the major curve Cobb's angle, patient in a standing posterior-anterior (PA) radiograph, the angle is composed of two intersecting lines: the upper endplate of the main thoracic curve upper vertebra and the lower endplate of the main curve lower vertebra. These lines meet at the point where the upper endplate of the main thoracic curve upper vertebra and the lower endplate of the main curve lower vertebra meet.

    Time frame: 10 months

07

Study locations

1 site
  • Cairo University
    Cairo, Giza 215879, Egypt
08

References and documents

Publications

  • Rao KE, Krodel D, Toaz EE, Fanelli J, Hajduk J, Kato K, Rychlik K, King E, Sarwark J, Grayhack J, Burjek NE. Introduction of an enhanced recovery pathway results in decreased length of stay in patients with adolescent idiopathic scoliosis undergoing posterior spinal fusion: A description of implementation strategies and retrospective before-and-after study of outcomes. J Clin Anesth. 2021 Dec;75:110493. doi: 10.1016/j.jclinane.2021.110493. Epub 2021 Sep 2. PubMed 34482261 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05803837
Lead sponsor
Cairo University
Responsible party
Khaled Takey Ahmed (Asssociate Professor, Cairo University) — Principal investigator
First posted
Apr 7, 2023
Start date
Mar 15, 2022
Primary completion
Nov 15, 2022
Completion
Nov 20, 2022
Last update
Apr 7, 2023

Study contacts

nisreen moh elnahass, Prof
study director · Cairo University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion